|
| | Ezetimibe Impurity Basic information |
| Product Name: | Ezetimibe Impurity | | Synonyms: | Ezetimibe IMP;(R)-N,5-bis(4-fluorophenyl)-2-(4-
hydroxybenzyl)pentanamide;(2R,3R,6S)-6-(4-fluorophenyl)-2-(4-hydroxyphenyl)-3,4,5,6-tetrahydro-2H-pyran-3-carboxylic acid;N,5-Bis(4-fluorophenyl)-2R-(4-hydroxybenzyl)pentanamide;Benzenepentanamide, 4-fluoro-N-(4-fluorophenyl)-α-[(4-hydroxyphenyl)methyl]-, (αR)-;3-Dehydroxy Ezetimibe Open Ring Impurity;Ezetimibe-11;Ezetimibe impuriry 13/(R)-N,5-bis(4-fluorophenyl)-2-(4-hydroxybenzyl)pentanamide | | CAS: | 1510820-22-0 | | MF: | C24H23F2NO2 | | MW: | 395.45 | | EINECS: | | | Product Categories: | | | Mol File: | 1510820-22-0.mol |  |
| | Ezetimibe Impurity Chemical Properties |
| Boiling point | 610.4±55.0 °C(Predicted) | | density | 1.246±0.06 g/cm3(Predicted) | | solubility | Dichloromethane; DMSO; Ethyl Acetate | | form | Solid | | pka | 10.04±0.15(Predicted) | | color | White |
| | Ezetimibe Impurity Usage And Synthesis |
| Uses | 3-Dehydroxy Ezetimibe Open Ring Impurity is an impurity in the synthesis of 3-Dehydroxy Ezetimibe, a derivative of Ezetimibe (E975000), an antihyperlipoproteinemic. A cholesterol absorption inhibitor. |
| | Ezetimibe Impurity Preparation Products And Raw materials |
|
